<DOC>
	<DOC>NCT00335712</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy, safety and pharmacokinetics of ONO-5129 in patients with type 2 diabetes mellitus.</brief_summary>
	<brief_title>Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>1. Fasting Blood Glucose 126250mg/dL 2. HbA1c 6.511% 1. Previous treatment with antidiabetic agents equal to or less than 23 months prior to randomization 2. History of myocardial infarction, coronary artery surgery 3. Other eligibility criteria as specified in the study protocol</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>ONO-5129</keyword>
	<keyword>type 2 diabetes mellitus</keyword>
</DOC>